Q5E9A1
Gene name |
NACA |
Protein name |
Nascent polypeptide-associated complex subunit alpha |
Names |
NAC-alpha, Alpha-NAC |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:513312 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q5E9A1
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q5E9A1-F1 | Predicted | AlphaFoldDB |
51 variants for Q5E9A1
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs482490953 | 4 | E>D | No | EVA | |
| rs446379139 | 7 | D>A | No | EVA | |
| rs457624228 | 8 | T>P | No | EVA | |
| rs479463898 | 9 | V>A | No | EVA | |
| rs479463898 | 9 | V>D | No | EVA | |
| rs468286662 | 11 | A>V | No | EVA | |
| rs450570461 | 12 | T>K | No | EVA | |
| rs435283281 | 12 | T>P | No | EVA | |
| rs433006098 | 13 | E>G | No | EVA | |
| rs451498164 | 15 | E>G | No | EVA | |
| rs473331750 | 16 | L>M | No | EVA | |
| rs434767097 | 18 | Q>P | No | EVA | |
| rs453274040 | 19 | P>A | No | EVA | |
| rs480146646 | 35 | V>I | No | EVA | |
| rs450568607 | 50 | Q>H | No | EVA | |
| rs462702702 | 54 | A>S | No | EVA | |
| rs478052106 | 55 | A>S | No | EVA | |
| rs478935667 | 56 | A>E | No | EVA | |
| rs478935667 | 56 | A>G | No | EVA | |
| rs460386920 | 56 | A>S | No | EVA | |
| rs466912760 | 74 | K>* | No | EVA | |
| rs435641201 | 75 | K>Q | No | EVA | |
| rs478309203 | 79 | A>S | No | EVA | |
| rs445329744 | 80 | M>I | No | EVA | |
| rs466948684 | 81 | S>A | No | EVA | |
| rs479003632 | 81 | S>F | No | EVA | |
| rs449428559 | 85 | L>H | No | EVA | |
| rs467885485 | 86 | R>* | No | EVA | |
| rs438306120 | 86 | R>Q | No | EVA | |
| rs464977098 | 87 | Q>R | No | EVA | |
| rs432018340 | 91 | V>A | No | EVA | |
| rs453825064 | 92 | T>N | No | EVA | |
| rs472329842 | 93 | R>T | No | EVA | |
| rs442631462 | 96 | I>S | No | EVA | |
| rs454741729 | 98 | K>* | No | EVA | |
| rs443519979 | 101 | N>K | No | EVA | |
| rs462860232 | 102 | I>F | No | EVA | |
| rs471806693 | 105 | V>F | No | EVA | |
| rs438823450 | 106 | I>S | No | EVA | |
| rs460461070 | 108 | K>Q | No | EVA | |
| rs478940505 | 110 | D>N | No | EVA | |
| rs449367290 | 115 | P>R | No | EVA | |
| rs461395786 | 125 | E>Q | No | EVA | |
| rs442888728 | 132 | S>Y | No | EVA | |
| rs461462532 | 142 | K>N | No | EVA | |
| rs483240692 | 144 | K>R | No | EVA | |
| rs450243277 | 146 | Q>H | No | EVA | |
| rs459231411 | 149 | A>T | No | EVA | |
| rs477788333 | 156 | N>D | No | EVA | |
| rs449261043 | 171 | V>I | No | EVA | |
| rs448180156 | 207 | V>G | No | EVA |
No associated diseases with Q5E9A1
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| nascent polypeptide-associated complex | A heterodimeric protein complex that can reversibly bind to ribosomes, and is located in direct proximity to newly synthesized polypeptide chains as they emerge from the ribosome. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| TBP-class protein binding | Binding to a member of the class of TATA-binding proteins (TBP), including any of the TBP-related factors (TRFs). |
| transcription coactivator activity | A transcription coregulator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coactivators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator. |
| unfolded protein binding | Binding to an unfolded protein. |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| protein targeting to membrane | The process of directing proteins towards a membrane, usually using signals contained within the protein. |
6 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q94518 | Nacalpha | Nascent polypeptide-associated complex subunit alpha | Drosophila melanogaster (Fruit fly) | PR |
| Q13765 | NACA | Nascent polypeptide-associated complex subunit alpha | Homo sapiens (Human) | PR |
| Q9BZK3 | NACA4P | Putative nascent polypeptide-associated complex subunit alpha-like protein | Homo sapiens (Human) | PR |
| Q86S66 | icd-2 | Nascent polypeptide-associated complex subunit alpha | Caenorhabditis elegans | PR |
| Q94JX9 | At3g49470 | Nascent polypeptide-associated complex subunit alpha-like protein 2 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q68F90 | naca | Nascent polypeptide-associated complex subunit alpha | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MPGEATDTVP | ATEQELPQPQ | AETGSGTESD | SDESVPELEE | QDSTQATTQQ | AQLAAAAEID |
| 70 | 80 | 90 | 100 | 110 | 120 |
| EEPVSKAKQS | RSEKKARKAM | SKLGLRQVTG | VTRVTIRKSK | NILFVITKPD | VYKSPASDTY |
| 130 | 140 | 150 | 160 | 170 | 180 |
| IVFGEAKIED | LSQQAQLAAA | EKFKVQGEAV | SNIQENTQTP | TVQEESEEEE | VDETGVEVKD |
| 190 | 200 | 210 | |||
| IELVMSQANV | SRAKAVRALK | NNSNDIVNAI | MELTM |